Astmabehandling i almen praksis
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Astmabehandling i almen praksis. / Behrendt, Victor; Hilberg, Ole; Bakker, Vibeke; Ulrik, Charlotte Suppli; Bjerring, Niels; Løkke, Anders.
In: Ugeskrift for Laeger, Vol. 184, No. 2, V03210221, 10.01.2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Astmabehandling i almen praksis
AU - Behrendt, Victor
AU - Hilberg, Ole
AU - Bakker, Vibeke
AU - Ulrik, Charlotte Suppli
AU - Bjerring, Niels
AU - Løkke, Anders
PY - 2022/1/10
Y1 - 2022/1/10
N2 - This review describes the current Danish guidelines for inhaled asthma treatment. Monotherapy with short-acting beta-agonists (SABA) taken when needed is no longer recommended in asthma therapy for adults due to safety concerns. The recommended first-line treatment is now inhaled corticosteroids (ICS) taken with formoterol or ICS taken with SABA. The choice of inhaler can have a significant impact on compliance and symptom control, and an individualized approach is therefore needed. Biological treatment may be an alternative to oral corticosteroids in selected patient groups.
AB - This review describes the current Danish guidelines for inhaled asthma treatment. Monotherapy with short-acting beta-agonists (SABA) taken when needed is no longer recommended in asthma therapy for adults due to safety concerns. The recommended first-line treatment is now inhaled corticosteroids (ICS) taken with formoterol or ICS taken with SABA. The choice of inhaler can have a significant impact on compliance and symptom control, and an individualized approach is therefore needed. Biological treatment may be an alternative to oral corticosteroids in selected patient groups.
KW - Administration, Inhalation
KW - Adrenal Cortex Hormones/therapeutic use
KW - Adult
KW - Anti-Asthmatic Agents/adverse effects
KW - Asthma/drug therapy
KW - Drug Therapy, Combination
KW - Ethanolamines/therapeutic use
KW - Formoterol Fumarate/therapeutic use
KW - General Practice
KW - Humans
M3 - Tidsskriftartikel
C2 - 35023469
VL - 184
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 2
M1 - V03210221
ER -
ID: 326024657